Cargando…
AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice
BACKGROUND: An orally active synthetic adiponectin receptor agonist, AdipoRon has been suggested to ameliorate insulin resistance, and glucose tolerance. However, the chronic effect of AdipoRon in the vascular dysfunction in type 2 diabetes has not been studied yet. Thus, in this study, we examined...
Autores principales: | Choi, Soo-Kyoung, Kwon, Youngin, Byeon, Seonhee, Haam, Chae Eun, Lee, Young-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077821/ https://www.ncbi.nlm.nih.gov/pubmed/32182257 http://dx.doi.org/10.1371/journal.pone.0230227 |
Ejemplares similares
-
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021) -
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019) -
Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice
por: Balasubramanian, Priya, et al.
Publicado: (2022) -
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
por: Manley, Sharon J., et al.
Publicado: (2022) -
Adiponectin receptor agonist AdipoRon blocks skin inflamm‐ageing by regulating mitochondrial dynamics
por: Sun, Jiachen, et al.
Publicado: (2021)